Researchers Identify a New, Vital Player in Graft-Versus-Host Disease and Organ Transplant Rejection

An RNA molecule, cataloged in scientific databases simply as Linc00402, helps activate immune defenders known as T cells in response to the presence of foreign human cells. Findings suggests inhibiting the RNA therapeutically might improve outcomes for transplant recipients.

Read more

Study Finds Immune Cell That Predicts Risk of Organ Rejection In Transplant Patients

Researchers at The Ohio State University College of Medicine are the first to identify an immune cell that may predict a transplant patient’s risk of developing antibodies that can cause organ rejection. This discovery could lead to the development of therapies to prevent complications after transplant surgery.

Read more